Scientists search for clue to make thyroid cancer treatment work again
NCT ID NCT07314255
Summary
This study looks back at medical records and tissue samples from 60 people with papillary thyroid cancer who received radioactive iodine therapy. Researchers are trying to see if a protein called Trop2 can help explain why some patients' cancers stop responding to this standard treatment. The goal is to gather knowledge that might lead to better predictions or new strategies in the future, not to test a new cure.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TROP2 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Jiangxi Cancer Hospital
Nanchang, Jiangxi, 330000, China
Conditions
Explore the condition pages connected to this study.